scholarly article | Q13442814 |
P2093 | author name string | R Offringa | |
C J Melief | |||
D Rea | |||
R E Toes | |||
F H Schagen | |||
M J Havenga | |||
M Mehtali | |||
R C Hoeben | |||
P2860 | cites work | Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells | Q46120101 |
A comparison of gene transfer methods in human dendritic cells | Q46153773 | ||
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell | Q47982760 | ||
Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. | Q52041455 | ||
Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. | Q54451826 | ||
Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones. | Q54560001 | ||
The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells | Q57275938 | ||
Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase | Q64380153 | ||
Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas ligand-induced apoptosis | Q64382129 | ||
High efficiency adenovirus-mediated gene transfer to human dendritic cells | Q64382219 | ||
Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides | Q67899941 | ||
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability | Q71615065 | ||
ICAM-1 expression on bronchial epithelium after recombinant adenovirus infection | Q72567256 | ||
The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation | Q74195817 | ||
Reciprocal control of T helper cell and dendritic cell differentiation | Q74452751 | ||
Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation | Q24677534 | ||
Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products | Q24678867 | ||
Dendritic cells and the control of immunity | Q27860918 | ||
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 | Q28303765 | ||
Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment | Q29615852 | ||
Novel role for E4 region genes in protection of adenovirus vectors from lysis by cytotoxic T lymphocytes | Q33651199 | ||
The human HLA-A*0201 allele, expressed in hamster cells, is not a high-affinity receptor for adenovirus type 5 fiber | Q33651315 | ||
In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. | Q33782356 | ||
CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. | Q33842878 | ||
The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis | Q35898131 | ||
Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice | Q36201407 | ||
Proliferating dendritic cell progenitors in human blood | Q36363279 | ||
B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation | Q36363323 | ||
High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. | Q36367196 | ||
Maturation, activation, and protection of dendritic cells induced by double-stranded RNA | Q36367830 | ||
Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells | Q36380589 | ||
Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells | Q36380614 | ||
Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity | Q36380749 | ||
Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression | Q36772633 | ||
A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses | Q36866762 | ||
Region E3 of adenovirus: A cassette of genes involved in host immunosurveillance and virus-cell interactions | Q37099438 | ||
Fas ligation induces apoptosis of CD40-activated human B lymphocytes | Q39018355 | ||
Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells | Q39875151 | ||
Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector | Q40951294 | ||
Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus. | Q40994268 | ||
ICAM-1 induction in respiratory cells exposed to a replication-deficient recombinant adenovirus in vitro and in vivo | Q41052038 | ||
Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. | Q41118985 | ||
Infection of A549 cells with a recombinant adenovirus vector induces ICAM-1 expression and increased CD-18-dependent adhesion of activated neutrophils | Q41168456 | ||
Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. | Q41237683 | ||
Activation of human dendritic cells through CD40 cross-linking. | Q41440958 | ||
Interactions of viruses with dendritic cells: a double-edged sword | Q41614150 | ||
Cytokines induce the development of functionally heterogeneous T helper cell subsets | Q41732572 | ||
Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells | Q42616240 | ||
Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination | Q44117606 | ||
Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells | Q45857101 | ||
Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation | Q45862591 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Adenoviridae | Q193447 |
dendritic cell | Q506253 | ||
P1104 | number of pages | 9 | |
P304 | page(s) | 10245-10253 | |
P577 | publication date | 1999-12-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset | |
P478 | volume | 73 |
Q64376825 | A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model |
Q36979919 | Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells |
Q36834545 | Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma |
Q34327129 | Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response |
Q37647530 | Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway |
Q34810377 | An Ad5[E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice |
Q33787309 | Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway |
Q41847338 | Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy |
Q64380401 | Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection |
Q34333200 | Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product |
Q30830095 | Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease |
Q36376315 | Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells |
Q35039002 | Gene-modified dendritic cells for immunotherapy against cancer |
Q40012083 | Genetically targeted adenovirus vector directed to CD40-expressing cells |
Q30426385 | Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity |
Q27469896 | Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis |
Q47677023 | Human dendritic cells infected with an adenoviral vector suppress proliferation of autologous and allogeneic T cells |
Q33842412 | Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. |
Q38839323 | Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors |
Q30657410 | Improved adenovirus vectors for infection of cardiovascular tissues |
Q35752100 | In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer |
Q33987398 | Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation |
Q33275292 | Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells |
Q36387951 | Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors |
Q35023724 | Mouse cytomegalovirus crosses the species barrier with help from a few human cytomegalovirus proteins |
Q39787669 | Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes. |
Q36628042 | Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses |
Q36746854 | Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease |
Q34353313 | Pulmonary immunity to viral infection: adenovirus infection of lung dendritic cells renders T cells nonresponsive to interleukin-2 |
Q33811694 | Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway |
Q40390251 | Recombinant adenovirus type 5 vectors that target DC-SIGN, ChemR23 and alpha(v)beta3 integrin efficiently transduce human dendritic cells and enhance presentation of vectored antigens |
Q37260718 | Targeting the porcine immune system--particulate vaccines in the 21st century |
Q36685596 | The conundrum between immunological memory to adenovirus and their use as vectors in clinical gene therapy. |
Q36802741 | Viral vector vaccines make memory T cells against malaria. |